| scholarly article | Q13442814 |
| P50 | author | Juan Carlos Corona | Q59700878 |
| Ricardo Tapia | Q89928016 | ||
| P2860 | cites work | Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels | Q49160604 |
| Preferential stimulation of glutamate release by 4-aminopyridine in rat striatum in vivo. | Q51582842 | ||
| Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis | Q28131805 | ||
| From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS | Q28206361 | ||
| Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients | Q28215473 | ||
| Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis | Q28335672 | ||
| On the relationship between extracellular glutamate, hyperexcitation and neurodegeneration, in vivo | Q33547438 | ||
| Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded | Q34175381 | ||
| Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis | Q34300016 | ||
| Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons | Q34511996 | ||
| Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis | Q41174676 | ||
| Expression of heat shock protein 70 induced by 4-aminopyridine through glutamate-mediated excitotoxic stress in rat hippocampus in vivo | Q44563676 | ||
| CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients | Q47631709 | ||
| Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis | Q48046641 | ||
| Decrease of glutamate decarboxylase activity after in vivo cortical infusion of gamma-aminobutyric acid | Q48146615 | ||
| Relationships among seizures, extracellular amino acid changes, and neurodegeneration induced by 4-aminopyridine in rat hippocampus: a microdialysis and electroencephalographic study | Q48227493 | ||
| AMPA receptor-mediated slow neuronal death in the rat spinal cord induced by long-term blockade of glutamate transporters with THA. | Q48542875 | ||
| NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord | Q48707656 | ||
| Neurotoxic effects of excitatory amino acids in the mouse spinal cord: quisqualate and kainate but not N-methyl-D-aspartate induce permanent neural damage | Q48880347 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 988-997 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | AMPA receptor activation, but not the accumulation of endogenous extracellular glutamate, induces paralysis and motor neuron death in rat spinal cord in vivo | |
| P478 | volume | 89 |
| Q38019570 | AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook |
| Q48709364 | Activation of group III metabotropic glutamate receptors by endogenous glutamate protects against glutamate-mediated excitotoxicity in the hippocampus in vivo |
| Q38089518 | Animal models for metabolic, neuromuscular and ophthalmological rare diseases. |
| Q46791864 | Calpain inhibition protects spinal motoneurons from the excitotoxic effects of AMPA in vivo. |
| Q42926951 | Calpastatin reduces toxicity of SOD1G93A in a culture model of amyotrophic lateral sclerosis |
| Q42044273 | Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons. |
| Q46592748 | Changes in glial fibrillary acidic protein (GFAP) immonureactivity reflect neuronal states |
| Q40609007 | Degeneration of spinal motor neurons by chronic AMPA-induced excitotoxicity in vivo and protection by energy substrates. |
| Q42563652 | Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo. |
| Q51824569 | EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis. |
| Q97066870 | Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology |
| Q39823079 | Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis |
| Q93108989 | Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases |
| Q37008837 | Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis. |
| Q33742729 | Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis |
| Q34408200 | In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. |
| Q41158540 | Motor Alterations Induced by Chronic 4-Aminopyridine Infusion in the Spinal Cord In vivo: Role of Glutamate and GABA Receptors |
| Q89584199 | Novel therapeutic targets for amyotrophic lateral sclerosis |
| Q47105356 | Quercetin prevents spinal motor neuron degeneration induced by chronic excitotoxic stimulus by a sirtuin 1-dependent mechanism |
| Q38257960 | Role of energy metabolic deficits and oxidative stress in excitotoxic spinal motor neuron degeneration in vivo |
| Q80069694 | Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS |
| Q36961660 | Survey of ALS-associated factors potentially promoting Ca2+ overload of motor neurons |
| Q46965352 | Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration |